Pharmafile Logo

Bridging Gaps with Virtual Meetings – Perks of Virtual Medical Education

Learn how virtual meetings can be used to review new data and minimize lengthy presentations, making every in-person interaction more productive and focused. Dive into the synergistic benefits of combining virtual and face-to-face meetings for a richer educational experience.

Discover how virtual meetings complement and enhance in-person interactions in our eighth video from the “Perks of Virtual Medical Education” series. Learn why virtual environments are indispensable tools for continuity in education and collaboration.

8. Virtual Meetings as a Supplement to In-Person Events Virtual meetings are not merely alternatives to in-person gatherings; they serve as essential supplements that enrich the overall meeting experience. By filling the “white space” between live events, virtual meetings prepare participants effectively, allowing them to engage with new data and concepts beforehand. This pre-meeting engagement reduces the need for extensive didactic presentations during the actual event, making in-person interactions more focused and productive. Virtual tools offer a flexible, efficient way to enhance understanding and readiness, ensuring that every moment of face-to-face time is used to its fullest potential.

For deeper insights into how virtual and in-person meetings can be synergistically integrated to maximize educational outcomes, visit our blog: https://www.impetusdigital.com/2020/09/17/top-10-reasons-why-virtual-collaboration-and-medical-education-will-persist-in-the-new-normal/

Enhance your educational strategies with Impetus Digital:

Stay connected for more innovative educational tips:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down...

Engaging KOLs & Gaining Insights in Pharma’s New Normal

Kaitlin Anstett, Senior Medical Advisor at Theratechnologies, shares her unique insights into the way Medical Affairs teams are changing the way they are engaging and interacting with their most important...

There’s No Going Back: How COVID-19 will Change Pharma Forever

Munther Baara, VP Product Strategy and Innovation at EDETEK, discusses all things clinical trials. Especially, we discuss the current gaps and the impact of COVID-19 on the way Pharma approaches...

Powering Rapid Cognitive Analysis with AI

Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.

KOL Ambassador Program & Podcast Creation: A Customer Story

Leveraging Impetus Digital’s best-in-class synchronous (real-time) and asynchronous (over-time, anytime) tools, our client facilitated a virtual ambassador program with three oncologist key opinion leaders (KOLs) from South Korea.The client’s main objectives...

Importance of Emotional Intelligence in Pharma and Medical Affairs

Emma Lynch, Founder of EQ Vibration & Quadrant 2 Medical, explores a number of interesting topics related to Medical Affairs. Among many other things, she discusses the importance of emotional...

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...